Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study

Oliver J. Gurney-Champion*, Eva Versteijne, Astrid van der Horst, Eelco Lens, Heidi Ruetten, Hanne D. Heerkens, Gabriel M. R. M. Paardekooper, Maaike Berbee, Coen R. N. Rasch, Jaap Stoker, Marc R. W. Engelbrecht, Marcel van Herk, Aart J. Nederveen, Remy Klaassen, Hanneke W. M. van Laarhoven, Geertjan van Tienhoven, Arjan Bel

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)923-930
Number of pages8
JournalActa Oncologica
Volume56
Issue number7
DOIs
Publication statusPublished - 2017

Keywords

  • TARGET VOLUME DELINEATION
  • RADIATION-THERAPY
  • INTRATUMORAL FIDUCIALS
  • OBSERVER VARIATION
  • QUALITY-ASSURANCE
  • CANCER ANALYSIS
  • SCALOP TRIAL
  • RADIOTHERAPY
  • VARIABILITY
  • MARKERS

Cite this

Gurney-Champion, O. J., Versteijne, E., van der Horst, A., Lens, E., Ruetten, H., Heerkens, H. D., Paardekooper, G. M. R. M., Berbee, M., Rasch, C. R. N., Stoker, J., Engelbrecht, M. R. W., van Herk, M., Nederveen, A. J., Klaassen, R., van Laarhoven, H. W. M., van Tienhoven, G., & Bel, A. (2017). Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study. Acta Oncologica, 56(7), 923-930. https://doi.org/10.1080/0284186X.2017.1304654